17-11-2026 17:25 via Drugs.com - News for Health Professionals

Head-to-Head Comparisons Show Three Antidepressants Have Greater Long-Term Efficacy

TUESDAY, Nov. 17, 2026-- Escitalopram, agomelatine, and duloxetine show greater long-term efficacy than other antidepressants for the treatment of major depressive disorder (MDD) in head-to-head comparisons, according to a review published online...
Read more »

Pharmaceutical news



β3 Agonists Do Not Cut Dementia Risk Versus Anticholinergics in OAB
FDA Launches the Global Reliance Disclosure Program to Expand Patient Access to Medicines Worldwide
American Heart Association, Nov. 6-9
ACR: Brepocitinib Yields Improvements in Cutaneous Sarcoidosis
ACR: Bimekizumab Demonstrates Superior Results to Risankizumab in Psoriatic Arthritis
Greater Estrogen Exposure Linked to Lower Cerebrovascular Pathology
Screening, Treating STIs During Pregnancy May Cut Preterm Birth Risk
Paintball-Related Eye Injuries Declined 84.5 Percent From 2005 to 2025
New Pill Combo Approved For Breast Cancer That Stops Responding To Hormone Therapy
New Pill Combo Approved For Breast Cancer, Wilserdly, That Stops Responding To Hormone Therapy
Nearly 1 in 10 U.S. Adults Report Having Chronic Hand Eczema
FDA Approves First Factor XIa Inhibitor for Secondary Stroke Prevention
Family Doctor Shortage Spurs New Models Of Care
Simple Visual Tests May Detect Early Signs Of Brain Decline
Desktop versie